Entering text into the input field will update the search result below

Lineage receives U.S. notice of allowance for two patents for spinal cord injury treatment

Patent concept with downtown Chicago cityscape

Melpomenem

  • Lineage Cell Therapeutics (NYSE:LCTX) said on Monday the United States Patent and Trademark Office had issued a notice of allowance to two patents for the company's application with claims covering manufacturing processes for its oligodendrocyte progenitor cell

Recommended For You

About LCTX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
LCTX--
Lineage Cell Therapeutics, Inc.